pharma manufacturing

Lilly’s Foundayo Approved: Weight-Loss Market Heats Up Foundayo pill bottles, blister packs, and two injection pens with a rising graph overlay, set against the US Capitol.

Foundayo pill bottles, blister packs, and two injection pens with a rising graph overlay, set against the US Capitol.

Lilly’s Foundayo Approved: Weight-Loss Market Heats Up

sivam April 2, 2026

FDA approves Eli Lilly's Foundayo for weight loss, intensifying competition with Novo Nordisk. A new oral option...

Novo Nordisk Cuts Ozempic, Wegovy Prices in India A map of India with medicine boxes, price arrows, and pens representing drug names, set against a cityscape.

A map of India with medicine boxes, price arrows, and pens representing drug names, set against a cityscape.

Novo Nordisk Cuts Ozempic, Wegovy Prices in India

sivam March 31, 2026

Novo Nordisk reduces Ozempic and Wegovy prices by up to 48% in India due to generic competition....

Lupin Gets Tentative USFDA Nod for Sugammadex Injection A scientist in a cleanroom holding a Sugammadex injection vial, with a USFDA logo on a screen in the background.

Lupin Gets Tentative USFDA Nod for Sugammadex Injection

sivam March 31, 2026

Lupin receives tentative USFDA approval for generic Sugammadex injection, a muscle relaxant reversal agent. Key step in...

Dr. Reddy’s ‘Olymviq’ Semaglutide: Legal Approval Granted A scientist in a lab coat and gloves views medicine vials with a holographic display of molecular structures.

A scientist in a lab coat and gloves views medicine vials with a holographic display of molecular structures.

Dr. Reddy’s ‘Olymviq’ Semaglutide: Legal Approval Granted

sivam March 30, 2026

Dr. Reddy's Laboratories secures temporary legal approval to market its semaglutide brand 'Olymviq' for 30 days. A...

Biocon Restructures Irish Subsidiary: Name Change Announced A professional image showing a modern, glass-fronted pharmaceutical building nestled in rolling green Irish hills under a bright sky.

A professional image showing a modern, glass-fronted pharmaceutical building nestled in rolling green Irish hills under a bright sky.

Biocon Restructures Irish Subsidiary: Name Change Announced

sivam March 30, 2026

Biocon Limited announced a name change for its Irish subsidiary, signaling a strategic restructuring move to streamline...

NovaBay Rebrands as Stablecoin Development Corp A split image showing a pharmaceutical lab on one side and a digital stablecoin interface on the other.

A split image showing a pharmaceutical lab on one side and a digital stablecoin interface on the other.

NovaBay Rebrands as Stablecoin Development Corp

sivam March 30, 2026

NovaBay Pharmaceuticals rebrands to Stablecoin Development Corporation, signaling a shift towards blockchain and digital assets. Details on...

India Considers Drug Price Controls Amid Supply Issues Assorted medicine capsules and tablets on a dark surface, with overlaid graphics representing policy and manufacturing.

Assorted medicine capsules and tablets on a dark surface, with overlaid graphics representing policy and manufacturing.

India Considers Drug Price Controls Amid Supply Issues

sivam March 29, 2026

India considers invoking 'Essentials' Act to control bulk drug prices due to supply chain vulnerabilities. Ensures affordable...

Supha Pharmachem Enters Insolvency: NCLT Order A man in a suit sits at a desk with a gavel and two monitors showing legal and corporate graphics.

Supha Pharmachem Enters Insolvency: NCLT Order

sivam March 28, 2026

Supha Pharmachem admitted into insolvency resolution by NCLT after payment defaults. Rajesh Jhunjhunwala appointed as resolution professional....

India Tightens GLP-1 Drug Distribution Oversight A hand holding a magnifying glass over GLP-1 drugs, with a pharma manufacturing plant in the background, symbolizing regulation.

A hand holding a magnifying glass over GLP-1 drugs, with a pharma manufacturing plant in the background, symbolizing regulation.

India Tightens GLP-1 Drug Distribution Oversight

sivam March 27, 2026

India's drug regulator enhances oversight of GLP-1 drug distribution to ensure compliance and prevent unauthorized sales. Stricter...

Dr. Reddy’s Labs Rebrands Drug to ‘Olymra’ After Legal Review A scientist in a lab coat oversees a drug manufacturing line with a magnified pill labeled Olymra and a legal shield icon.